期刊
SCIENCE OF ADVANCED MATERIALS
卷 14, 期 5, 页码 829-835出版社
AMER SCIENTIFIC PUBLISHERS
DOI: 10.1166/sam.2022.4251
关键词
Endometrial Cancer; Nanoparticle Albumin-Bound Paclitaxel; Cell Proliferation
资金
- Norman Bethune Medical Science Research Fund [B19006CS]
- Natural Science Foundation of Fujian Province [2018J01265]
This study compared the antitumor efficacy and toxicity of nab-paclitaxel and paclitaxel, and found that nab-paclitaxel was more effective in inhibiting cancer cell growth, inducing apoptosis, and causing G1 arrest in the cell cycle.
Nab-paclitaxel is a water-soluable formulation of paclitaxel. It is more effective and less toxic than paclitaxel in treating cancer. Here we compared nab-paclitaxel with paclitaxel for their antitumor efficacy and toxicity in vitro and in a murine endometrial cancer model. Nab-paclitaxel was more effective than paclitaxel in inhibiting cancer cell growth. Nab-paclitaxel also caused cell apoptosis and cell cycle G1 arrest more effectively than paclitaxel. Similar effect was observed in mice model of endometrial cancer. In summary this preliminary study shows nab-paclitaxel is a promising therapeutic agent for endometrial cancer and deserves further studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据